Eli Lilly and Company Cash from Operations Quarterly:
379.40M for March 31, 2013Eli Lilly and Company Historical Cash from Operations Quarterly Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | 379.40M |
| Dec. 31, 2012 | 1.602B |
| Sept. 30, 2012 | 1.544B |
| June 30, 2012 | 1.306B |
| March 31, 2012 | 852.50M |
| Dec. 31, 2011 | 1.945B |
| Sept. 30, 2011 | 2.073B |
| June 30, 2011 | 2.040B |
| March 31, 2011 | 1.176B |
| Dec. 31, 2010 | 2.228B |
| Sept. 30, 2010 | 1.759B |
| June 30, 2010 | 1.912B |
| March 31, 2010 | 958.00M |
| Dec. 31, 2009 | 2.019B |
| Sept. 30, 2009 | 1.306B |
| June 30, 2009 | 923.30M |
| March 31, 2009 | 87.90M |
| Dec. 31, 2008 | 2.380B |
| Sept. 30, 2008 | 2.132B |
| June 30, 2008 | 1.081B |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
| Dec. 31, 2000 | Go Pro |
About Cash From Operations
An item on a company's cash flow statement. Lists aggregate change in cash position resulting from operations. Includes the company's cash inflows and outflows from the company's core business operations.
Cash from Operations can be thought of as "how much did the firm generate in the day to day operations of the firm?"
Learn More
LLY Cash from Operations Quarterly Benchmarks
| Companies | |
|---|---|
| Pfizer | |
| Merck | |
| Bristol-Myers Squibb | -428.00M |
LLY Cash from Operations Quarterly Rankings
| Overall |
96th percentile 308 of 8002 |
| Sector |
97th percentile 19 of 650 in Healthcare |
| Industry |
90th percentile 5 of 52 in Drug Manufacturers - Major |
LLY Cash from Operations Quarterly Range, Past 5 Years
| Minimum | 87.90M | Mar 2009 |
| Maximum | 2.380B | Dec 2008 |
| Average | 1.485B |